Filed: 5/15/2026ACC: 0000905148-26-002409
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $280.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$280.55M
Total AUM (reported)
23.41M
Total Shares
Allocation by class
COM$280.55M100.0%
Portfolio Concentration
Top 3$256.65M91.5%
4–10$23.90M8.5%
Top 3 weight
91.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 23.41M
Sole
Full voting authority
23.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.64M
TypeSH
Market value$131.06M
46.71%
Sole
4.64M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares4.53M
TypeSH
Market value$99.76M
35.56%
Sole
4.53M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares12.88M
TypeSH
Market value$25.83M
9.21%
Sole
12.88M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares489.19K
TypeSH
Market value$13.70M
4.88%
Sole
489.19K
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares337.70K
TypeSH
Market value$6.77M
2.41%
Sole
337.70K
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares531.34K
TypeSH
Market value$3.42M
1.22%
Sole
531.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.64M | SH | $131.06M 46.71% | 4.64M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 4.53M | SH | $99.76M 35.56% | 4.53M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 12.88M | SH | $25.83M 9.21% | 12.88M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 489.19K | SH | $13.70M 4.88% | 489.19K | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM | 337.70K | SH | $6.77M 2.41% | 337.70K | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 531.34K | SH | $3.42M 1.22% | 531.34K | 0.00 | 0.00 |